Skip to main content

Share story

Capital AI

Orakl Oncology raises $34M to expand cancer drug prediction platform

Orakl Oncology raises $34M to expand cancer drug prediction platform Image: Primary
Paris-based Orakl Oncology has raised a $34M Series A co-led by Norrsken VC and Singular, bringing total funding to $50M. The company grows small copies of patients' tumours, tests drugs on them and combines the results with medical records to train AI that predicts clinical trial outcomes. The financing will support five times more laboratory data, expansion into lung and gastric cancers, and teams in the US and UK. An April preprint tested the model retrospectively on 23 colorectal and pancreatic cancer trials, mostly involving standard chemotherapy; performance on newer drugs still needs to be proven.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from The Next Web and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital AI
Capital AI

Norwest raises $4 billion fund targeting AI startups and overlooked sectors

Wells Fargo & Co.-backed Norwest has raised $4 billion for its latest investment fund, Bloomberg reported. The fund will target early-stage AI startups alongside deals in sectors other investors have overlooked. The firm plans to announce the fund Thursday.

Infrastructure
Infrastructure

Rowan raises about $1.5 billion to advance data center projects

Rowan Digital Infrastructure raised about $1.5 billion in fresh financing from lenders including Citigroup, Bloomberg reported. The Blackstone-backed data center developer is seeking to advance its growing pipeline of projects with the new financing from lenders.

Capital AI
Capital AI

Axle raises $9M for investment bank meeting software and AI agents

Axle raised $9M in a round led by Eniac and Bonfire Ventures, with Teamworthy Ventures also participating, the startup announced Thursday. Its software helps investment banks arrange meetings between investors and company management, analysts and industry experts.